Literature DB >> 23946457

Dual split protein-based fusion assay reveals that mutations to herpes simplex virus (HSV) glycoprotein gB alter the kinetics of cell-cell fusion induced by HSV entry glycoproteins.

Doina Atanasiu1, Wan Ting Saw, John R Gallagher, Brian P Hannah, Zene Matsuda, J Charles Whitbeck, Gary H Cohen, Roselyn J Eisenberg.   

Abstract

Herpes simplex virus (HSV) entry and cell-cell fusion require glycoproteins gD, gH/gL, and gB. We propose that receptor-activated changes to gD cause it to activate gH/gL, which then triggers gB into an active form. We employed a dual split-protein (DSP) assay to monitor the kinetics of HSV glycoprotein-induced cell-cell fusion. This assay measures content mixing between two cells, i.e., fusion, within the same cell population in real time (minutes to hours). Titration experiments suggest that both gD and gH/gL act in a catalytic fashion to trigger gB. In fact, fusion rates are governed by the amount of gB on the cell surface. We then used the DSP assay to focus on mutants in two functional regions (FRs) of gB, FR1 and FR3. FR1 contains the fusion loops (FL1 and FL2), and FR3 encompasses the crown at the trimer top. All FL mutants initiated fusion very slowly, if at all. However, the fusion rates caused by some FL2 mutants increased over time, so that total fusion by 8 h looked much like that of the WT. Two distinct kinetic patterns, "slow and fast," emerged for mutants in the crown of gB (FR3), again showing differences in initiation and ongoing fusion. Of note are the fusion kinetics of the gB syn mutant (LL871/872AA). Although this mutant was originally included as an ongoing high-rate-of-fusion control, its initiation of fusion is so rapid that it appears to be on a "hair trigger." Thus, the DSP assay affords a unique way to examine the dynamics of HSV glycoprotein-induced cell fusion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23946457      PMCID: PMC3807322          DOI: 10.1128/JVI.01700-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Bimolecular complementation reveals that glycoproteins gB and gH/gL of herpes simplex virus interact with each other during cell fusion.

Authors:  Doina Atanasiu; J Charles Whitbeck; Tina M Cairns; Brigid Reilly; Gary H Cohen; Roselyn J Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

2.  Herpes simplex virus glycoprotein B associates with target membranes via its fusion loops.

Authors:  Brian P Hannah; Tina M Cairns; Florent C Bender; J Charles Whitbeck; Huan Lou; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

3.  Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition.

Authors:  Hiroaki Uchida; Waris A Shah; Ali Ozuer; Arthur R Frampton; William F Goins; Paola Grandi; Justus B Cohen; Joseph C Glorioso
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

4.  The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines.

Authors:  Jan Kadlec; Silvia Loureiro; Nicola G A Abrescia; David I Stuart; Ian M Jones
Journal:  Nat Struct Mol Biol       Date:  2008-09-07       Impact factor: 15.369

5.  Mutational evidence of internal fusion loops in herpes simplex virus glycoprotein B.

Authors:  Brian P Hannah; Ekaterina E Heldwein; Florent C Bender; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

6.  Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans.

Authors:  Adam L Vanarsdall; Brent J Ryckman; Marie C Chase; David C Johnson
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

7.  Contribution of endocytic motifs in the cytoplasmic tail of herpes simplex virus type 1 glycoprotein B to virus replication and cell-cell fusion.

Authors:  Igor Beitia Ortiz de Zarate; Lilia Cantero-Aguilar; Magalie Longo; Clarisse Berlioz-Torrent; Flore Rozenberg
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

8.  Extensive mutagenesis of the HSV-1 gB ectodomain reveals remarkable stability of its postfusion form.

Authors:  Elvira Vitu; Sapna Sharma; Samuel D Stampfer; Ekaterina E Heldwein
Journal:  J Mol Biol       Date:  2013-03-13       Impact factor: 5.469

9.  Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B.

Authors:  Marija Backovic; Richard Longnecker; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

Review 10.  Viral membrane fusion.

Authors:  Stephen C Harrison
Journal:  Nat Struct Mol Biol       Date:  2008-07       Impact factor: 15.369

View more
  29 in total

1.  Displacement of the C terminus of herpes simplex virus gD is sufficient to expose the fusion-activating interfaces on gD.

Authors:  John R Gallagher; Wan Ting Saw; Doina Atanasiu; Huan Lou; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

2.  Regulation of Herpes Simplex Virus Glycoprotein-Induced Cascade of Events Governing Cell-Cell Fusion.

Authors:  Doina Atanasiu; Wan Ting Saw; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

3.  Mutations in Pseudorabies Virus Glycoproteins gB, gD, and gH Functionally Compensate for the Absence of gL.

Authors:  Christina Schröter; Melina Vallbracht; Jan Altenschmidt; Sabrina Kargoll; Walter Fuchs; Barbara G Klupp; Thomas C Mettenleiter
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

4.  Using Split Luciferase Assay and anti-HSV Glycoprotein Monoclonal Antibodies to Predict a Functional Binding Site Between gD and gH/gL.

Authors:  Doina Atanasiu; Wan Ting Saw; Tina M Cairns; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2021-01-27       Impact factor: 5.103

5.  Using Antibodies and Mutants To Localize the Presumptive gH/gL Binding Site on Herpes Simplex Virus gD.

Authors:  Doina Atanasiu; Wan Ting Saw; Eric Lazear; J Charles Whitbeck; Tina M Cairns; Huan Lou; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

6.  Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB.

Authors:  Nina Reuter; Barbara Kropff; Julia Karin Schneiderbanger; Mira Alt; Adalbert Krawczyk; Christian Sinzger; Thomas H Winkler; William J Britt; Michael Mach; Marco Thomas
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

7.  Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B.

Authors:  Tina M Cairns; Juan Fontana; Zhen-Yu Huang; J Charles Whitbeck; Doina Atanasiu; Samhita Rao; Spencer S Shelly; Huan Lou; Manuel Ponce de Leon; Alasdair C Steven; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

8.  Epstein-Barr Virus Fusion with Epithelial Cells Triggered by gB Is Restricted by a gL Glycosylation Site.

Authors:  Britta S Möhl; Jia Chen; Seo Jin Park; Theodore S Jardetzky; Richard Longnecker
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 9.  Animal models of herpes simplex virus immunity and pathogenesis.

Authors:  Christina M Kollias; Richard B Huneke; Brian Wigdahl; Stephen R Jennings
Journal:  J Neurovirol       Date:  2014-11-12       Impact factor: 2.643

10.  Localization of the Interaction Site of Herpes Simplex Virus Glycoprotein D (gD) on the Membrane Fusion Regulator, gH/gL.

Authors:  Tina M Cairns; Doina Atanasiu; Wan Ting Saw; Huan Lou; J Charles Whitbeck; Noah T Ditto; Birgitte Bruun; Helena Browne; Lucas Bennett; Chun Wu; Claude Krummenacher; Benjamin D Brooks; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.